Galvão-Coelho NL

Postgraduate Program in Mental Health and Behavior, Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Center for Advanced Medical Psychedelics (CAMP), Natal, Rio Grande do Norte, Brazil; Psychobiology Postgraduate Program, Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil; Laboratory of Hormone Measurement and Postgraduate Program of Psychobiology Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil; Western Sydney University, NICM Health Research Institute, Westmead, NSW, Australia; National Science and Technology Institute for Translational Medicine (INCT-TM), Brazil. Electronic address: nicole.galvao@ufrn.br.

Galvão-Coelho NL

Dissociation and antidepressant response to subcutaneous esketamine: A clinical study.

N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine.

Preliminary analysis of ayahuasca-induced anatomical alterations in the somatosensory cortex of juvenile non-human primates (Callithrix jacchus) subjected to chronic stress.

Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein.

Ayahuasca partially preserves striatal integrity in juvenile non-human primates exposed to chronic stress: evidence from stereological evaluation.

Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in Depression.

Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.

Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.

Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice.

Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression.

Default Mode Network Modulation by Psychedelics: A Systematic Review.

Moderators of ayahuasca's biological antidepressant action.

Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior.

Psychedelic medicines for mood disorders: current evidence and clinical considerations.

Ayahuasca for the Treatment of Depression.

Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.

Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial.

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.

Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls.